Pharma & Biotech

The dissolution of biotechnology firm Vyant Bio continues to proceed at a slower pace than initially outlined. While shareholders approved...

The investment thesis for biopharmaceutical company Ocugen is gaining notable support on Wall Street. In a significant endorsement, the firm...

Today marks a significant confluence of events for Healwell AI Inc. The company is releasing its complete fiscal 2025 annual...

French vaccine specialist Valneva has unveiled its full-year 2025 results, presenting a nuanced financial picture that underscores a significant improvement...

The biotech firm Ocugen has staged a remarkable recovery in recent months, capturing renewed attention from institutional investors. This resurgence...

In a move that sent shockwaves through the market, global banking giant HSBC has downgraded its stance on Eli Lilly...

The telehealth company Hims & Hers has taken a decisive step into the competitive GLP-1 market. It has now opened...

Biopharmaceutical firm CytomX Therapeutics has positioned itself for a significant clinical push following a substantial equity raise. The company confirmed...

For shareholders of Gene Biotherapeutics, the wait for substantive news continues. The company, formerly known as Taxus Cardium Pharmaceuticals Group,...

The biopharmaceutical giant AbbVie finds itself navigating a complex landscape where promising research initiatives are counterbalanced by resurgent legal challenges....